Literature DB >> 14715418

Constitutive expression of TGF-bêta1, interleukin-6 and interleukin-8 by tumor cells as a major component of immune escape in human ovarian carcinoma.

Olivier Toutirais1, Patricia Chartier, Damien Dubois, Françoise Bouet, Jean Lévêque, Véronique Catros-Quemener, Noëlle Genetet.   

Abstract

Tumors could use several mechanisms to coexist with the host's immune system or to protect themselves from an immune response. Thus, insufficient expression of cell surface molecules on tumor cells, which are important for T cell recognition or activation, could lead to induction of a state of tolerance. Tumor cells could also produce cytokines that would inhibit the immune response and allow tumor progression. Here, we studied, in vitro, the cell surface expression of immunologically important molecules in seven ovarian carcinoma (OVCA) cell lines and the constitutive expression of cytokines. All OVCA cell lines expressed MHC class I molecules, ICAM-1 and LFA-3 adhesion molecules, necessary to induce a specific cytotoxic T-cell response, as well as the CD40 costimulatory molecules. Conversely, the lack of the dominant costimulatory molecules, CD80 (B7.1) and CD86 (B7.2) could be a possible explanation of poor immunogenicity of OVCA tumors. Immunosuppressive TGF-beta1 was detected at the mRNA level in all cell lines but was weakly secreted in supernatants. By contrast, IL-10 was never found. Most of them constitutively produced IL-8 and IL-6, two cytokines known as tumor promoting factors whereas the proinflammatory cytokines TNF-alpha, IL-1beta and GM-CSF were rarely produced. Data from this study could be useful for designing new strategies of immunotherapy to improve immunogenicity and/or limit protumor cytokine production. Copyright John Libbey Eurotext 2003.

Entities:  

Mesh:

Substances:

Year:  2003        PMID: 14715418

Source DB:  PubMed          Journal:  Eur Cytokine Netw        ISSN: 1148-5493            Impact factor:   2.737


  16 in total

1.  The immunosuppressive surface ligand CD200 augments the metastatic capacity of squamous cell carcinoma.

Authors:  Magda Stumpfova; Desirée Ratner; Edward B Desciak; Yehuda D Eliezri; David M Owens
Journal:  Cancer Res       Date:  2010-03-23       Impact factor: 12.701

2.  Anti-tumor immunostimulatory effect of heat-killed tumor cells.

Authors:  Taek Joon Yoon; Ji Yeon Kim; Hyojeong Kim; Changwan Hong; Hyunji Lee; Chang Kwon Lee; Kwang Ho Lee; Seokmann Hong; Se Ho Park
Journal:  Exp Mol Med       Date:  2008-02-29       Impact factor: 8.718

3.  Expression of interleukin-1 (IL-1) ligands system in the most common endometriosis-associated ovarian cancer subtypes.

Authors:  Mamadou Keita; Paul Bessette; Manuella Pelmus; Youssef Ainmelk; Aziz Aris
Journal:  J Ovarian Res       Date:  2010-01-28       Impact factor: 4.234

Review 4.  Pre-treatment effects of peripheral tumors on brain and behavior: neuroinflammatory mechanisms in humans and rodents.

Authors:  Andrew Schrepf; Susan K Lutgendorf; Leah M Pyter
Journal:  Brain Behav Immun       Date:  2015-05-06       Impact factor: 7.217

Review 5.  Targeting human inducible regulatory T cells (Tr1) in patients with cancer: blocking of adenosine-prostaglandin E₂ cooperation.

Authors:  Magis Mandapathil; Theresa L Whiteside
Journal:  Expert Opin Biol Ther       Date:  2011-06-26       Impact factor: 4.388

6.  Interleukin-6 and vascular endothelial growth factor release by renal cell carcinoma cells impedes lymphocyte-dendritic cell cross-talk.

Authors:  F Cabillic; F Bouet-Toussaint; O Toutirais; N Rioux-Leclercq; P Fergelot; C Thomas de la Pintière; N Genetet; J-J Patard; V Catros-Quemener
Journal:  Clin Exp Immunol       Date:  2006-12       Impact factor: 4.330

7.  Epithelial ovarian cancer-induced angiogenic phenotype of human omental microvascular endothelial cells may occur independently of VEGF signaling.

Authors:  Boleslaw K Winiarski; Katarzyna I Wolanska; Srijana Rai; Tahanver Ahmed; Nigel Acheson; Nicholas J Gutowski; Jacqueline L Whatmore
Journal:  Transl Oncol       Date:  2013-12-01       Impact factor: 4.243

Review 8.  Tumor escape mechanisms: potential role of soluble HLA antigens and NK cells activating ligands.

Authors:  M Campoli; S Ferrone
Journal:  Tissue Antigens       Date:  2008-08-12

9.  Effects of CD40 binding on ovarian carcinoma cell growth and cytokine production in vitro.

Authors:  O Toutirais; A Gervais; F Cabillic; M Le Gallo; A Coudrais; J Levêque; V Catros-Quemener; N Genetet
Journal:  Clin Exp Immunol       Date:  2007-06-12       Impact factor: 4.330

10.  Tumour-derived prostaglandin E and transforming growth factor-beta synergize to inhibit plasmacytoid dendritic cell-derived interferon-alpha.

Authors:  Isabelle Bekeredjian-Ding; Meike Schäfer; Evelyn Hartmann; Ralph Pries; Marijo Parcina; Philip Schneider; Thomas Giese; Stefan Endres; Barbara Wollenberg; Gunther Hartmann
Journal:  Immunology       Date:  2009-11       Impact factor: 7.397

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.